This is a preview of subscription content, log in via an institution to check access.
Notes
Using a 22-score esophageal squamous cell carcinoma risk (ESCC) prediction model.
Input data were taken from published literature, and direct medical costs were taken from a local multicentre randomised trial.
Reference
Xia R, et al. Cost-effectiveness of risk-stratified endoscopic screening for esophageal cancer in high-risk areas of China: a modeling study. Gastrointestinal Endoscopy : 18 Aug 2021. Available from: URL: http://doi.org/10.1016/j.gie.2021.08.008
Rights and permissions
About this article
Cite this article
Risk-stratified endoscopic screening for cancer cost effective up to 55 years of age in China. PharmacoEcon Outcomes News 887, 23 (2021). https://doi.org/10.1007/s40274-021-08039-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-08039-1